GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Metagenomi Inc (NAS:MGX) » Definitions » Total Liabilities

MGX (Metagenomi) Total Liabilities : $89.74 Mil (As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Metagenomi Total Liabilities?

Metagenomi's Total Liabilities for the quarter that ended in Dec. 2024 was $89.74 Mil.

Metagenomi's quarterly Total Liabilities declined from Jun. 2024 ($116.49 Mil) to Sep. 2024 ($102.58 Mil) and declined from Sep. 2024 ($102.58 Mil) to Dec. 2024 ($89.74 Mil).

Metagenomi's annual Total Liabilities increased from Dec. 2022 ($488.91 Mil) to Dec. 2023 ($500.43 Mil) but then declined from Dec. 2023 ($500.43 Mil) to Dec. 2024 ($89.74 Mil).


Metagenomi Total Liabilities Historical Data

The historical data trend for Metagenomi's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Metagenomi Total Liabilities Chart

Metagenomi Annual Data
Trend Dec21 Dec22 Dec23 Dec24
Total Liabilities
174.54 488.91 500.43 89.74

Metagenomi Quarterly Data
Dec21 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 500.43 139.77 116.49 102.58 89.74

Metagenomi Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Metagenomi's Total Liabilities for the fiscal year that ended in Dec. 2024 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=37.309+(40.186+2.01
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+10.237+0+0)
=89.74

Total Liabilities=Total Assets (A: Dec. 2024 )-Total Equity (A: Dec. 2024 )
=324.599-234.857
=89.74

Metagenomi's Total Liabilities for the quarter that ended in Dec. 2024 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=37.309+(40.186+2.01
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+10.237+0+0)
=89.74

Total Liabilities=Total Assets (Q: Dec. 2024 )-Total Equity (Q: Dec. 2024 )
=324.599-234.857
=89.74

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Metagenomi Total Liabilities Related Terms

Thank you for viewing the detailed overview of Metagenomi's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Metagenomi Business Description

Traded in Other Exchanges
N/A
Address
5959 Horton Street, Emeryville, CA, USA, 94608
Metagenomi Inc is a genetic medicines company committed to developing curative therapeutics for patients using its proprietary, comprehensive metagenomics-derived genome editing toolbox. Genetic diseases are caused by a diverse set of mutations that have been largely inaccessible by genome engineering approaches to date. The genome editing toolbox includes programmable nucleases, base editors, and RNA and DNA-mediated integration systems (including prime editing systems and clustered regularly interspaced short palindromic repeat (CRISPR)-associated transposases (CASTs).